Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 5
2005 9
2006 7
2007 4
2008 5
2009 1
2010 6
2011 4
2012 4
2013 6
2015 3
2016 3
2017 6
2018 5
2019 2
2020 7
2021 5
2022 5
2023 4
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Neoantigen Controversies.
Castro A, Zanetti M, Carter H. Castro A, et al. Among authors: zanetti m. Annu Rev Biomed Data Sci. 2021 Jul 20;4:227-253. doi: 10.1146/annurev-biodatasci-092820-112713. Epub 2021 May 11. Annu Rev Biomed Data Sci. 2021. PMID: 34465181 Free PMC article. Review.
A community affair in the tumor microenvironment.
Rodvold JJ, Kesari S, Zanetti M. Rodvold JJ, et al. Among authors: zanetti m. Oncotarget. 2017 Nov 21;8(63):106173-106174. doi: 10.18632/oncotarget.22586. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29290938 Free PMC article. No abstract available.
The Unfolded Protein Response at the Tumor-Immune Interface.
Zanetti M, Xian S, Dosset M, Carter H. Zanetti M, et al. Front Immunol. 2022 Feb 14;13:823157. doi: 10.3389/fimmu.2022.823157. eCollection 2022. Front Immunol. 2022. PMID: 35237269 Free PMC article. Review.
Ubi Maior Minor Cessat.
Zanetti M. Zanetti M. Crit Rev Immunol. 2020;40(3):255-262. doi: 10.1615/CritRevImmunol.2020034859. Crit Rev Immunol. 2020. PMID: 33389889
Telomerase and CD4 T Cell Immunity in Cancer.
Dosset M, Castro A, Carter H, Zanetti M. Dosset M, et al. Among authors: zanetti m. Cancers (Basel). 2020 Jun 25;12(6):1687. doi: 10.3390/cancers12061687. Cancers (Basel). 2020. PMID: 32630460 Free PMC article. Review.
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Pagadala M, Sears TJ, Wu VH, Pérez-Guijarro E, Kim H, Castro A, Talwar JV, Gonzalez-Colin C, Cao S, Schmiedel BJ, Goudarzi S, Kirani D, Au J, Zhang T, Landi T, Salem RM, Morris GP, Harismendy O, Patel SP, Alexandrov LB, Mesirov JP, Zanetti M, Day CP, Fan CC, Thompson WK, Merlino G, Gutkind JS, Vijayanand P, Carter H. Pagadala M, et al. Among authors: zanetti m. Nat Commun. 2023 May 12;14(1):2744. doi: 10.1038/s41467-023-38271-5. Nat Commun. 2023. PMID: 37173324 Free PMC article.
CD4 T cells in tumor immunity.
Gerloni M, Zanetti M. Gerloni M, et al. Among authors: zanetti m. Springer Semin Immunopathol. 2005 Jun;27(1):37-48. doi: 10.1007/s00281-004-0193-z. Epub 2005 Mar 15. Springer Semin Immunopathol. 2005. PMID: 15965712 Review.
92 results